523144 MEDICAPQ

MediCaps Share Price

₹49.70 +0.53 (1.08%)

30 Jan, 2025 10:58

SIP TrendupStart SIP in MEDICAPQ

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 2.03%
  • Over 3 Month -4.44%
  • Over 6 Month -1.04%
  • Over 1 Year -14.97%
SIP Lightning

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹49.70
+ 0.53 (1.08%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹50.51
  • 50 Day
  • ₹50.81
  • 100 Day
  • ₹50.86
  • 200 Day
  • ₹50.21

Resistance and Support

48.89 Pivot Speed
  • R3 52.78
  • R2 51.39
  • R1 50.28
  • S1 47.78
  • S2 46.39
  • S3 45.28

What's your outlook on MediCaps?

You can only vote for once

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-07 Quarterly Results
2024-05-23 Quarterly Results
2024-02-08 Quarterly Results
2023-11-08 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

No data available.

About MediCaps

  • NSE Symbol
  • MEDICAPQ
  • BSE Symbol
  • 523144
  • ISIN
  • INE442D01010

Similar Stocks to MediCaps

MediCaps FAQs

MediCaps share price is ₹49 As on 30 January, 2025 | 10:44

The Market Cap of MediCaps is ₹62 Cr As on 30 January, 2025 | 10:44

The P/E ratio of MediCaps is -41.7 As on 30 January, 2025 | 10:44

The PB ratio of MediCaps is 0.5 As on 30 January, 2025 | 10:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23